Valuation: Laboratorio Reig Jofre, S.A.

Market Cap 217M 252M 202M 186M 349M 24.13B 355M 2.39B 934M 12.1B 948M 927M 40.01B P/E 2026 *
13.3x
P/E 2027 * 22.2x
Enterprise Value 301M 351M 281M 258M 485M 33.57B 493M 3.32B 1.3B 16.84B 1.32B 1.29B 55.66B EV / Sales 2026 *
0.83x
EV / Sales 2027 * 0.75x
Free-Float
20.57%
Yield 2026 *
-
Yield 2027 * -
1 day+0.38%
1 week-0.37%
1 month+1.53%
3 months-1.85%
6 months-0.37%
Current year+3.50%
1 week 2.64
Extreme 2.64
2.7
1 month 2.62
Extreme 2.62
2.78
Current year 2.32
Extreme 2.32
2.94
1 year 2.32
Extreme 2.32
3.35
3 years 2.15
Extreme 2.15
3.4
5 years 2.02
Extreme 2.02
5.1
10 years 1.87
Extreme 1.87
6.4
Manager TitleAgeSince
Chief Executive Officer 58 2005-12-31
Director of Finance/CFO - 2023-12-19
Chief Tech/Sci/R&D Officer - 2002-12-31
Director TitleAgeSince
Chairman - 2014-12-30
Director/Board Member 58 2014-12-30
Director/Board Member - 2017-11-06
Date Insider Type Main position Quantity % Market Cap.
12/1/22 Buy

Director

2,363 0.0030%
12/1/22 Buy

Director

1 0.0000%
12/1/22 Buy

Director

640 0.0008%
Change 5-day change 1-year change 3-year change Capi.($)
+0.38%-0.37%-10.14%+3.91% 250M
+4.46%+5.38%+83.42%+134.31% 1,093B
+0.85%+5.24%+55.13%+58.51% 653B
+2.72%+6.35%+28.76%+77.15% 458B
+1.80%-0.41%+43.52%+44.05% 355B
+1.24%+1.00%+26.84%+42.21% 294B
+2.07%+1.74%+2.66%+13.06% 248B
+4.02%+6.77%+51.17%+68.96% 230B
+1.05%-2.52%-13.83%-52.13% 203B
+2.90%+8.71%+25.10%+94.52% 178B
Average +1.77%+1.01%+29.26%+48.45% 371.07B
Weighted average by Cap. +1.53%+1.45%+47.89%+73.73%

Financials

2026 *2027 *
Net sales 365M 425M 341M 313M 588M 40.66B 598M 4.02B 1.57B 20.39B 1.6B 1.56B 67.42B 392M 457M 366M 336M 631M 43.67B 642M 4.32B 1.69B 21.9B 1.72B 1.68B 72.41B
Net income 16.7M 19.47M 15.59M 14.31M 26.9M 1.86B 27.35M 184M 72.05M 933M 73.1M 71.51M 3.09B 9.5M 11.07M 8.87M 8.14M 15.3M 1.06B 15.56M 105M 40.99M 531M 41.58M 40.68M 1.76B
Net Debt 84.7M 98.74M 79.09M 72.56M 136M 9.44B 139M 933M 365M 4.73B 371M 363M 15.65B 78.7M 91.75M 73.49M 67.42M 127M 8.77B 129M 867M 340M 4.4B 344M 337M 14.54B
Logo Laboratorio Reig Jofre, S.A.
Laboratorio Reig Jofre SA, formerly Natraceutical SA, is a Spain-based company primarily engaged in the research, development, manufacturing and marketing of drugs. The Company’s activities are divided into four business divisions: Industrial Services, providing production services for third parties; Pharma, selling own pharmaceuticals under a range of brands, such as Reig Jofre, Medea, Orravan, Bioglan and Sala; Reaserch and Development (R&D) and Regulatory, including the development of indications for existing molecules, as well as generics and molecular diagnostics, among others; and Biotech, offering biopharmaceutical support services, such as analytical and process development, quality control and assurance, as well as stability studies. The Company also provides nutritional cosmetics, and food supplements, among others. It operates worldwide in Europe, Africa, the Americas, Australia and Asia through a number of subsidiaries, including Chiesi Espana SA and Oryzon Genomics SA.
Employees
1,512
Date Price Change Volume
26-08-19 €2.660 +0.38% 2,499
26-08-18 €2.650 -0.38% 5,930
26-08-17 €2.660 -0.37% 3,347
26-08-14 €2.670 -0.37% 1,275
26-08-13 €2.680 0.00% 247
Trader
-
Investor
Global
-
Quality
ESG MSCI
-

Annual profits - Rate of surprise